Dimitrios Paraskevis

10.9k total citations · 3 hit papers
212 papers, 5.4k citations indexed

About

Dimitrios Paraskevis is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Dimitrios Paraskevis has authored 212 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Infectious Diseases, 112 papers in Epidemiology and 76 papers in Virology. Recurrent topics in Dimitrios Paraskevis's work include HIV Research and Treatment (76 papers), HIV/AIDS Research and Interventions (72 papers) and HIV, Drug Use, Sexual Risk (54 papers). Dimitrios Paraskevis is often cited by papers focused on HIV Research and Treatment (76 papers), HIV/AIDS Research and Interventions (72 papers) and HIV, Drug Use, Sexual Risk (54 papers). Dimitrios Paraskevis collaborates with scholars based in Greece, United States and United Kingdom. Dimitrios Paraskevis's co-authors include Angelos Hatzakis, Gkikas Magiorkinis, Evangelia Georgia Kostaki, Vana Sypsa, Sotirios Tsiodras, Georgios K. Nikolopoulos, Emmanouil Magiorkinis, George Sourvinos, Anne–Mieke Vandamme and Samuel R. Friedman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Dimitrios Paraskevis

203 papers receiving 5.3k citations

Hit Papers

Full-genome evolutionary ... 2020 2026 2022 2024 2020 2021 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dimitrios Paraskevis Greece 37 3.2k 2.3k 1.5k 1.0k 613 212 5.4k
Deenan Pillay United Kingdom 56 6.3k 2.0× 3.2k 1.4× 5.0k 3.3× 918 0.9× 701 1.1× 302 9.5k
Angelos Hatzakis Greece 43 2.5k 0.8× 4.7k 2.1× 932 0.6× 3.4k 3.3× 234 0.4× 221 7.0k
Fujie Zhang China 30 3.1k 1.0× 1.4k 0.6× 1.4k 0.9× 262 0.3× 296 0.5× 179 4.1k
Éster Cerdeira Sabino Brazil 45 3.6k 1.1× 2.4k 1.1× 1.9k 1.2× 588 0.6× 707 1.2× 414 7.6k
Jan Fehr Switzerland 38 2.0k 0.6× 1.4k 0.6× 581 0.4× 486 0.5× 538 0.9× 195 5.7k
Nicola P. Klein United States 52 2.8k 0.9× 5.5k 2.4× 270 0.2× 579 0.6× 711 1.2× 295 10.0k
Jacques Fellay Switzerland 35 1.9k 0.6× 3.0k 1.4× 1.3k 0.9× 3.1k 3.0× 1.1k 1.8× 133 7.7k
Vana Sypsa Greece 32 1.2k 0.4× 2.1k 0.9× 411 0.3× 1.0k 1.0× 141 0.2× 132 3.4k
Marie Paule Kiény France 40 1.4k 0.5× 1.9k 0.9× 1.5k 0.9× 404 0.4× 1.3k 2.1× 108 5.6k
Annemarie Berger Germany 35 1.7k 0.5× 1.8k 0.8× 736 0.5× 995 1.0× 401 0.7× 130 3.7k

Countries citing papers authored by Dimitrios Paraskevis

Since Specialization
Citations

This map shows the geographic impact of Dimitrios Paraskevis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Paraskevis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Paraskevis more than expected).

Fields of papers citing papers by Dimitrios Paraskevis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios Paraskevis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Paraskevis. The network helps show where Dimitrios Paraskevis may publish in the future.

Co-authorship network of co-authors of Dimitrios Paraskevis

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Paraskevis. A scholar is included among the top collaborators of Dimitrios Paraskevis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Paraskevis. Dimitrios Paraskevis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Surleac, Marius, Oana Săndulescu, Daniela Pițigoi, et al.. (2025). Ongoing measles outbreak in Romania: Clinical investigation and molecular epidemiology performed on whole genome sequences. PLoS ONE. 20(1). e0317045–e0317045. 2 indexed citations
2.
Kostoglou, Margaritis, Maria Petala, Thodoris D. Karapantsios, et al.. (2024). Effect of SARS-CoV-2 shedding rate distribution of individuals during their disease days on the estimation of the number of infected people. Application of wastewater-based epidemiology to the city of Thessaloniki, Greece. The Science of The Total Environment. 951. 175724–175724. 1 indexed citations
3.
Ridgway, Harry, Christos T. Chasapis, Konstantinos Kelaidonis, et al.. (2023). Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity. Viruses. 15(2). 309–309. 19 indexed citations
4.
Koureas, Michalis, Kassiani Μellou, Maria Kyritsi, et al.. (2023). Wastewater Levels of Respiratory Syncytial Virus Associated with Influenza-like Illness Rates in Children—A Case Study in Larissa, Greece (October 2022–January 2023). International Journal of Environmental Research and Public Health. 20(6). 5219–5219. 16 indexed citations
5.
Vlachogiannis, Nikolaos I., Μαρία Παππά, Evrydiki Kravvariti, et al.. (2023). Chronological Age and DNA Damage Accumulation in Blood Mononuclear Cells: A Linear Association in Healthy Humans after 50 Years of Age. International Journal of Molecular Sciences. 24(8). 7148–7148. 1 indexed citations
6.
Roussos, Sotirios, Dimitrios Paraskevis, Mina Psichοgiou, et al.. (2022). Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014–20). Addiction. 117(6). 1670–1682. 4 indexed citations
7.
Chaintoutis, Serafeim C., Ioanna Stylianaki, Sofia Michailidou, et al.. (2021). Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination. PLoS Pathogens. 17(9). e1009883–e1009883. 25 indexed citations
8.
Morgan, Ethan, Britt Skaathun, Georgios K. Nikolopoulos, et al.. (2018). A Network Intervention to Locate Newly HIV Infected Persons Within MSM Networks in Chicago. AIDS and Behavior. 23(1). 15–20. 21 indexed citations
9.
Kostaki, Evangelia Georgia, Timokratis Karamitros, Bobkova Mr, et al.. (2018). Spatiotemporal Characteristics of the HIV-1 CRF02_AG/CRF63_02A1 Epidemic in Russia and Central Asia. AIDS Research and Human Retroviruses. 34(5). 415–420. 13 indexed citations
10.
Olson, Ashley, Norbert Bannert, Anders Sönnerborg, et al.. (2017). Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort. AIDS. 32(2). 161–169. 20 indexed citations
11.
Nikolopoulos, Georgios K., Anastasios Fotiou, Clive Richardson, et al.. (2015). National Income Inequality and Declining GDP Growth Rates Are Associated with Increases in HIV Diagnoses among People Who Inject Drugs in Europe: A Panel Data Analysis. PLoS ONE. 10(4). e0122367–e0122367. 34 indexed citations
12.
Paraschiv, Simona, et al.. (2014). Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains. AIDS Research and Human Retroviruses. 31(5). 488–495. 36 indexed citations
13.
Paraskevis, Dimitrios, Giota Touloumi, Giorgos Bakoyannis, et al.. (2012). Effect of HIV Type 1 Subtype on Virological and Immunological Response to Combination Antiretroviral Therapy: Evidence for a More Rapid Viral Suppression for Subtype A Than Subtype B-Infected Greek Individuals. AIDS Research and Human Retroviruses. 29(3). 461–469. 7 indexed citations
14.
Vandamme, Anne–Mieke, Ricardo Camacho, Francesca Ceccherini‐Silberstein, et al.. (2011). European recommendations for the clinical use of HIV drug resistance testing: 2011 update.. PubMed. 13(2). 77–108. 104 indexed citations
15.
Cornelissen, Marion, Dimitrios Paraskevis, Maria Prins, et al.. (2010). HIV Transmission Patterns Among The Netherlands, Suriname, and The Netherlands Antilles: A Molecular Epidemiological Study. AIDS Research and Human Retroviruses. 27(2). 123–130. 12 indexed citations
16.
Magiorkinis, Emmanouil, et al.. (2008). Emergence of an NNRTI Resistance Mutation Y181C in an HIV-Infected NNRTI-Naive Patient. AIDS Research and Human Retroviruses. 24(3). 413–415. 3 indexed citations
17.
Poveda, Eva, Verónica Briz, Dimitrios Paraskevis, et al.. (2007). Short Communication: Dynamics of Drug-Resistant HIV-1 in Plasma and Peripheral Blood Cells in Patients during and after Enfuvirtide Therapy. AIDS Research and Human Retroviruses. 23(9). 1078–1082. 8 indexed citations
18.
Anastassopoulou, Cleo, et al.. (2003). Genetic Evolution of Human Immunodeficiency Virus Type 1 in Two Spouses Responding Successfully to Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 19(1). 65–71. 1 indexed citations
19.
Hatzakis, Angelos, Panagiotis Gargalianos, Marios Lazanas, et al.. (2001). Low-Dose IFN- α Monotherapy in Treatment-Naive Individuals with HIV-1 Infection: Evidence of Potent Suppression of Viral Replication. Journal of Interferon & Cytokine Research. 21(10). 861–869. 43 indexed citations
20.
Paraskevis, Dimitrios, et al.. (2000). Molecular Characterization of a Recombinant HIV Type 1 Isolate (A/G/E/?): Unidentified Regions May Be Derived from Parental Subtype E Sequences. AIDS Research and Human Retroviruses. 16(9). 845–855. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026